Target intelligence / Profile preview

MicroRNA 1910 (miR-1910)

Target
miR-1910
Molecular classification
MicroRNA, Noncoding RNA, Other
01

Overview

MicroRNA 1910 (miR-1910) is a small, noncoding RNA molecule found in Homo sapiens that belongs to the microRNA (miRNA) family. Like other miRNAs, miR-1910 is transcribed as part of a precursor molecule, processed into a mature ∼22 nucleotide RNA, and functions mainly to negatively regulate gene expression at the post-transcriptional level. miRNAs achieve this by binding complementary sequences on target messenger RNAs (mRNAs), leading to mRNA degradation or inhibition of translation. While miRNAs in general are implicated in diverse biological processes—including cell proliferation, apoptosis, and differentiation—the specific biological functions and disease associations of miR-1910 are not well characterized in the current scientific literature. miR-1910 is not classified as a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor, but forms part of the broader regulatory RNA landscape. It is not considered a therapeutic target in the conventional sense (e.g., receptors, enzymes), and there is no evidence it is currently a direct target of therapeutic drugs, nor is it widely recognized as a biomarker or subject of safety concerns. This entry is flagged as incorrect because "microRNA 1910" is not a therapeutic target as generally defined, and the name provided is appropriate for a miRNA, not for a classical druggable target class.

Other names
hsa-miR-1910MIRN1910hsa-mir-1910mir-1910MIR1910
02

Biological functions

Gene expression regulationPost-transcriptional regulationOther
03

Disease associations

Other

Beyond the preview

Go deeper on MicroRNA 1910 (miR-1910).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1910 (miR-1910).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call